Chlamydia pneumoniaeSecretion of a Protease-Like Activity Factor for Degrading Host Cell Transcription Factors Is Required for Major Histocompatibility Complex Antigen Expression
Open Access
- 1 January 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (1) , 345-349
- https://doi.org/10.1128/iai.70.1.345-349.2002
Abstract
Chlamydia pneumoniae is a causative agent for many respiratory infections and has been associated with cardiovascular diseases in humans. The pathogenicity of C. pneumoniae is thought to depend on its ability to cause persistent infection and to evade host defense. Genome sequence analysis indicates that C. pneumoniae encodes a homologue of a chlamydial protease-like activity factor from C. trachomatis (CPAFct). We designated the C. pneumoniae homologue as CPAFcp. Recombinant CPAFcp was produced and found to degrade RFX5, a host transcription factor required for major histocompatibility complex (MHC) antigen expression. The degradation was inhibitable by lactacystin, an irreversible proteasome inhibitor. Furthermore, CPAFcp was secreted into host cytosol by C. pneumoniae organisms. Depletion of the C. pneumoniae-secreted CPAFcp with specific antibodies completely ablated the RFX5 degradation activity in the infected cells, suggesting that CPAFcp is necessary for the degradation of host transcription factors required for MHC antigen expression during C. pneumoniae infection. These observations have revealed a unique molecular mechanism for C. pneumoniae to evade host adaptive immunity that may aid in its persistence.Keywords
This publication has 35 references indexed in Scilit:
- Identification of a Chlamydial Protease–Like Activity Factor Responsible for the Degradation of Host Transcription FactorsThe Journal of Experimental Medicine, 2001
- Mouse Models ofC. pneumoniaeInfection and AtherosclerosisThe Journal of Infectious Diseases, 2000
- Chlamydia pneumoniae–Induced Atherosclerosis in a Rabbit ModelThe Journal of Infectious Diseases, 2000
- Chlamydia pneumoniaein Atherosclerotic and Nonatherosclerotic TissueThe Journal of Infectious Diseases, 2000
- Antibiotics Effects in a Rabbit Model ofChlamydia pneumoniae–Induced AtherosclerosisThe Journal of Infectious Diseases, 2000
- Chlamydia pneumoniaein Atherosclerotic TissueThe Journal of Infectious Diseases, 2000
- Collaborative Multidisciplinary Workshop Report: What Questions Regarding the Role ofChlamydia pneumoniaein Atherosclerosis and Cardiovascular Disease Need to Be Addressed Utilizing Animal Models?The Journal of Infectious Diseases, 2000
- Degradation of Transcription Factor Rfx5 during the Inhibition of Both Constitutive and Interferon γ–Inducible Major Histocompatibility Complex Class I Expression in Chlamydia-Infected CellsThe Journal of Experimental Medicine, 2000
- The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniaeJournal of Clinical Investigation, 1999
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994